The global urinalysis market was valued at US$ 1,609.8 Mn in 2022 and is forecast to reach a value of US$ 2,669.2 Mn by 2030 at a CAGR of 6.5% between 2023 and 2030.
Global Urinalysis Market Trends:
Rising use of point of care testing is a recent trend
Point-of-care (POC) testing is a medical term used to describe diagnostic testing that is performed in the patient's unit rather than in the hospital's central lab or outside a reference lab. Point-of-care tests can be a vital tool to help patients and their babies across reproductive and fertility medicine. In April 2022, Mankind Pharma announced the launch of the rapid-testing pregnancy device that is used for urinalysis to confirm pregnancy. It is a single-step pregnancy test device that does not require the collection of urine in a dropper or a container, making it the easiest and most convenient method to test pregnancy at home.
Technological advancements is another trend
Continuous technological advancements in urinalysis equipment and point-of-care testing devices have improved accuracy, speed, and ease of use, promoting the adoption of urinalysis tests across various healthcare settings worldwide. New technological advancements have also paved the way for significant progress in automated urinalysis. Each system uses a different technology to classify and quantify urine sediment particles and offers an improvement in standardization over manual microscopy by eliminating potential inter-technician variability during slide interpretation. This in turn is also expected to augment the growth of the market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients